Sino Biopharmaceutical Limited (SBMFF) R&D/CAPEX US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 138.3% 141.3% 197.8% 254.0% 258.4%    
Changes by years, y/y, % +15pp +3pp +57pp +56pp +4pp     +15.9%

Sino Biopharmaceutical Limited. R&D/CAPEX, %

Created with Highcharts 6.0.6123.5123.5138.3138.3141.3141.3197.8197.8254.0254.0258.4258.4201820192020202120222023LTM050100150200250300smart-lab.ru

Sino Biopharmaceutical Limited. R&D/CAPEX, changes, pp

Created with Highcharts 6.0.614.814.82.92.956.656.656.256.24.44.4-258.4-258.420192020202120222023LTM-300-250-200-150-100-50050100smart-lab.ru

Sino Biopharmaceutical Limited. R&D/CAPEX, %

Created with Highcharts 6.0.6smart-lab.ru

Sino Biopharmaceutical Limited. R&D/CAPEX, changes, pp

Created with Highcharts 6.0.6smart-lab.ru

Sino Biopharmaceutical Limited. R&D/CAPEX, changes, pp

Created with Highcharts 6.0.6smart-lab.ru